In ovarian cancer, mutation of the TP53 gene appears to play an important role in serous carcinogenesis, where TP53 mutations are present in approximately 50% of high-grade serous carcinomas but rare in serous borderline tumours and low-grade serous carcinoma [11,12]. Here, TP53 is linked to ovarian carcinoma.